Mavatar Discovery
Mavatar Discovery™: Early access waitlist now open
Mavatar Discovery is preparing for launch — and we’re building something game-changing.
Join the Waitinglist!
Our beta is now officially closed, but the momentum is just beginning. As we gear up for our full commercial launch in Fall 2025, Mavatar Discovery is expanding rapidly — with richer datasets, broader disease coverage, and smarter, more powerful analytics designed to uncover deeper insights into disease biology.
We’ve already seen incredible feedback from our beta users. Here’s what one had to say
We’ve already seen incredible feedback from our beta users. Here’s what one had to say
"Mavatar Discovery gave us the ability to explore disease mechanisms and cross-disease patterns in a way we’ve never seen before. The platform’s 100% data-driven insights are not only novel—they’re biologically meaningful"
Join the Waitinglist!
Be among the first to experience the next generation of discovery.
Join our early-access waitlist and you can get a front-row seat to Mavatar Discovery before the public launch.
Join our early-access waitlist and you can get a front-row seat to Mavatar Discovery before the public launch.
"Sneak peek: What’s coming: "
1. Single-Cell UMAP
Projects every cell in a single-cell RNA-seq experiment onto a 2-D map where closeness reflects transcriptomic similarity. By removing the need to juggle stand-alone UMAP apps, this feature speeds hypothesis generation and keeps biological context visible.
Use case: In a tumor atlas, a researcher selects a cell interaction network and instantly sees its clusters.
Use case: In a tumor atlas, a researcher selects a cell interaction network and instantly sees its clusters.
2. Thorough Gene and GSE Descriptions
Every node and dataset card now carry a plain-language summary and the experimental design behind the GEO Series (GSE). Context that once lived in scattered tabs is embedded beside the graph, cutting literature-lookup time and reducing annotation errors.
Use case: While exploring synaptic-plasticity networks, a neuroscientist immediately learns that GSE12345 used sleep-deprived mice, prompting her to control for circadian effects.
Use case: While exploring synaptic-plasticity networks, a neuroscientist immediately learns that GSE12345 used sleep-deprived mice, prompting her to control for circadian effects.
3. Dual-Network Union Analysis
Loads any two gene-interaction networks, and the viewer highlights shared hubs, unique edges, and enriched pathways in real time. This one-click comparison replaces manual scripts and spreadsheets, letting you instantly spot, for example, condition-specific rewiring.
4. Biomarker Specificity & Sensitivity Metrics
This quantitative layer prevents wasted validation on flashy but weak markers.
5. Network Similarity Scatter Plot
This panoramic view lets you discover related datasets, detect outliers, or build meta-analysis cohorts without laborious pairwise tests.
Why join the waiting list?
· A complete, ready-to-use solution – No complex setup, just powerful, actionable ready to use insights that will speed up your research, study or drug development process.
· All-Inclusive data integration – Combine public datasets with your own research.
· Breakthrough analytics – Discover trends, biomarkers, and drug development opportunities with unparalleled depth.
What you’ll gain
An integrated platform that turns overwhelming amounts of biological data into clear, research-ready insights—removing the manual effort and accelerating your path to Discovery.
Get on the list today
Join our waiting list to stay informed and get priority access as we roll out Mavatar Discovery to more users.
More info
Download our one pager for more indepth information about Mavatar Discovery.
Join the Mavatar Discovery™
Waiting List
Mavatar Discovery is currently in a closed BETA with selected partners.
Register your interest and we’ll notify you as soon as access opens up.
Register your interest and we’ll notify you as soon as access opens up.
MAVATAR DISCOVERY
Be among the first to access Mavatar Discovery, our groundbreaking self-service platform designed for pharmaceutical companies, CROs, researchers, and academia.
While our closed beta is already in motion, we’re now opening up a waiting list for those who want early access once we expand.
While our closed beta is already in motion, we’re now opening up a waiting list for those who want early access once we expand.
MAVATAR DISCOVERY
Mavatar Discovery unlocks deep, integrated network analysis of disease mechanisms—across genes, cells, and signaling pathways—powered by massive amounts of public data.
MAVATAR DISCOVERY
It’s a complete, cloud-based solution that transforms months of research into minutes of actionable insights—ready to use from day one.